Belite Bio, Inc (BLTE) Financials

BLTE Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 811.3 million 15.5 million
Dec. 31, 2025 780.6 million 10.1 million
Sept. 30, 2025 282.4 million 8.3 million
June 30, 2025 156.4 million 6.5 million

BLTE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 ? ?
Dec. 31, 2025 -10.6 million 11.7 million
Sept. 30, 2025 ? ?
June 30, 2025 ? ?

BLTE Net Income

No data available :(

BLTE Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 - - -
Dec. 31, 2025 492.4 million - 429000
Sept. 30, 2025 275.6 million - 510000
June 30, 2025 - - -

BLTE Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 39.9 million
Dec. 31, 2025 33.5 million
Sept. 30, 2025 33.2 million
June 30, 2025 32.6 million

BLTE Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 15.7 million 17.0 million -
Dec. 31, 2025 178000 14.6 million 13.5 million -
Sept. 30, 2025 - 10.3 million 12.7 million -
June 30, 2025 - 11.0 million 6.5 million -

BLTE Cost of Revenue

No data available :(

BLTE

Price: $144.31

52 week price:
56.10
200.00

Earnings Per Share: -2.54 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 5.7 billion

Links: